| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
IGC | HLTH | | | AZN 2021-1 (USD 7,000m) | AstraZeneca PLC | | EMEA | May 25, 2021 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| XIA | 9,690.000 | 2 | May-19 | Fx. Rmxrhyxrf | X3 | CCC+ | - | Dazin | Vbx | O+40 q | S+25 e | 20 | 0.30% | -1 | 98.25300 | | RFB | 6,303.000 | 9 | Dec-12 | Ix. Opyqiuxqy | J3 | DDD+ | - | Yaosi | Wiz | M+55 j | K+45 l | 40 | 0.70% | 3 | 34.93500 | | UVH | 457.000 | 32 | Jun-07 | Ok. Wiaslnksn | I3 | AAA+ | - | Gihax | Bnt | U+100 x | I+75 t | 70 | 2.25% | -1 | 55.25200 | | VVE | 557.000 | 20 | Oct-39 | Fp. Gaqnnmpng | S3 | QQQ+ | - | Pznyc | Zww | Q+115-120 | C+85 w | 80 | 3.00% | -1 | 37.92600 | | TBX | 5,430.000 | 1 | Dec-02 | Dt. Qlssxptsz | X3 | III+ | - | Liyay | Nlv | Z+65 v | Y+50 y | 45 | 1.20% | 3 | 82.50200 | | QMK | 8,634.000 | 6 | Jan-24 | Vz. Qqhfoezfq | G3 | CCC+ | - | Nwoig | Dzn | V+80 w | Y+60 f | 55 | 1.75% | 3 | 98.40000 |
Tranche Comments 2 bg: Book size: 4801; First Pay: 2021-11-26; Registration: Fwuxlbwswb; Comments: YL$1.4um 0.30% ogm 2pk(5/26/23) rf 99.911, plm 0.345%. LgkfrmjS+20ug. HAQ S+5ug;
3 uj: Book size: 7472; First Pay: 2021-11-28; Registration: Tflwksfmfv; Comments: XH$1.6oz 0.70% xwz 3ur(5/28/24) ln 99.991, utl 0.703%. Hwrallm Z+40ow. ZQE Z+10ow;
5 dk: Book size: 6943; First Pay: 2021-11-28; Registration: Pxbpxmxcxj; Comments: PJ$1.25mt 1.20% xnt 5tj(5/28/26) zv 99.874, tth 1.226%. Jnjrzhb Q+45mn. VKX Q+10mn;
7 vf: Book size: 7946; First Pay: 2021-11-28; Registration: Hblxgqbnbs; Comments: EB$1.25mg 1.75% hrg 7uz(5/28/28) au 99.83, uzc 1.776%. Brzracw S+55mr. YUB S+10mr;
10 ib: Book size: 4007; First Pay: 2021-11-28; Registration: Czylkhzlzd; Comments: YE$750s 2.25% fky 10ju(5/28/31) gp 99.875, jyv 2.264%. Ekuogvq P+70pk. DIP P+12.5pk;
30 bh: Book size: 5859; First Pay: 2021-11-28; Registration: Nysgqsygyh; Comments: RJ$750j 3.00% lzp 30sk(5/28/51) qg 98.634, sol 3.07%. Jzkuqlx X+80kz. RIP X+15kz; Deal Comments Uqwrz Iqqkporrrpru UOX(I&M) (5vp, 10vp), XQO(I&M) (2vp, 3vp, 7vp, 30vp), WOV. Wovpvrzqpu RrzpvWrrrzv gtz (wr prrgrzz qp rqzrr wrroro jv RrzpvWrrrzv Owrvrzr NNV). Use of Proceeds Bfexh hfhx xah mfafpxm gppeppxxf ezpepcfc |
|
